Literature DB >> 20385507

Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.

T A Winkel1, S E Hoeks, O Schouten, U Zeymer, T Limbourg, I Baumgartner, D L Bhatt, Ph G Steg, S Goto, J Röther, P P Cacoub, H J M Verhagen, J J Bax, D Poldermans.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is a significant risk factor for cardiovascular (CV) mortality. This study aims to evaluate the prognostic implication of AF in patients with peripheral arterial disease (PAD).
METHODS: The International Reduction of Atherothrombosis for Continued Health (REACH) Registry included 23,542 outpatients in Europe with established coronary artery disease, cerebrovascular disease (CVD), PAD and/or > or =3 risk factors. Of these, 3753 patients had symptomatic PAD. CV risk factors were determined at baseline. Study end point was a combination of cardiac death, non-fatal myocardial infarction (MI) and stroke (CV events) during 2 years of follow-up. Cox regression analysis adjusted for age, gender and other risk factors (i.e., congestive heart failure, coronary artery re-vascularisation, coronary artery bypass grafting (CABG), MI, hypertension, stroke, current smoking and diabetes) was used.
RESULTS: Of 3753 PAD patients, 392 (10%) were known to have AF. Patients with AF were older and had a higher prevalence of CVD, diabetes and hypertension. Long-term CV mortality occurred in 5.6% of patients with AF and in 1.6% of those without AF (p<0.001). Multivariable analyses showed that AF was an independent predictor of late CV events (hazard ratio (HR): 1.5; 95% confidence interval (CI): 1.09-2.0).
CONCLUSION: AF is common in European patients with symptomatic PAD and is independently associated with a worse 2-year CV outcome. Copyright 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20385507     DOI: 10.1016/j.ejvs.2010.03.003

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  17 in total

Review 1.  Primary and key secondary results from the ROCKET AF trial, and their implications on clinical practice.

Authors:  Rohan Shah; Manesh R Patel
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-09-19

2.  The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study.

Authors:  Ada Man; Yanyan Zhu; Yuqing Zhang; Maureen Dubreuil; Young Hee Rho; Christine Peloquin; Robert W Simms; Hyon K Choi
Journal:  Ann Rheum Dis       Date:  2012-08-17       Impact factor: 19.103

Review 3.  Atrial fibrillation and risk of cardiovascular events and mortality in patients with symptomatic peripheral artery disease: A meta-analysis of prospective studies.

Authors:  Mislav Vrsalović; Ana Vrsalović Presečki
Journal:  Clin Cardiol       Date:  2017-12-15       Impact factor: 2.882

4.  Atrial Fibrillation Predicts Cardiovascular Outcome in Hypertensive Patients With Symptomatic Peripheral Artery Disease and Preserved Ejection Fraction.

Authors:  Mislav Vrsalovic; Ksenija Vucur; Bojan Jelakovic
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-03-14       Impact factor: 3.738

5.  Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE Trial.

Authors:  Peter T Hu; Renato D Lopes; Susanna R Stevens; Lars Wallentin; Laine Thomas; John H Alexander; Michael Hanna; Basil S Lewis; Freek W A Verheugt; Christopher B Granger; W Schuyler Jones
Journal:  J Am Heart Assoc       Date:  2017-01-17       Impact factor: 5.501

Review 6.  β-blockade: benefits beyond blood pressure reduction?

Authors:  John R Cockcroft; Michala E Pedersen
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-11-11       Impact factor: 3.738

Review 7.  Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Focused Review on Oral Anticoagulation.

Authors:  José Miguel Rivera-Caravaca; Anny Camelo-Castillo; Inmaculada Ramírez-Macías; Pablo Gil-Pérez; Cecilia López-García; María Asunción Esteve-Pastor; Esteban Orenes-Piñero; Antonio Tello-Montoliu; Francisco Marín
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

Review 8.  Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches?

Authors:  Gregory Y H Lip; Sana M Al-Khatib; Francisco G Cosio; Amitava Banerjee; Irina Savelieva; Jeremy Ruskin; Dan Blendea; Stanley Nattel; Joseph De Bono; Jennifer M Conroy; Paul L Hess; Eduard Guasch; Jonathan L Halperin; Paulus Kirchhof; M Dolores G Cosio; A John Camm
Journal:  J Am Heart Assoc       Date:  2014-08-27       Impact factor: 5.501

Review 9.  Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms.

Authors:  Francesco Violi; Elsayed Z Soliman; Pasquale Pignatelli; Daniele Pastori
Journal:  J Am Heart Assoc       Date:  2016-05-20       Impact factor: 5.501

10.  Immediate results and long-term cardiovascular outcomes of endovascular therapy in octogenarians and nonoctogenarians with peripheral arterial diseases.

Authors:  Hsuan-Li Huang; Jyh-Ming Jimmy Juang; Hsin-Hua Chou; Chien-An Hsieh; Shih-Jung Jang; Shih-Tsung Cheng; Yu-Lin Ko
Journal:  Clin Interv Aging       Date:  2016-05-04       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.